Stock Yards Bank Trust Co Lowers stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Stock Yards Bank Trust Co reduced its stake in Cardinal Health Inc by 7.04% during the most recent quarter end. The investment management company now holds a total of 2,907 shares of Cardinal Health Inc which is valued at $218,810 after selling 220 shares in Cardinal Health Inc , the firm said in a disclosure report filed with the SEC on Oct 14, 2016.Cardinal Health Inc makes up approximately 0.03% of Stock Yards Bank Trust Co’s portfolio.

Other Hedge Funds, Including , Legal General Group Plc reduced its stake in CAH by selling 20,208 shares or 1.15% in the most recent quarter. The Hedge Fund company now holds 1,730,959 shares of CAH which is valued at $130,375,832. Cardinal Health Inc makes up approx 0.13% of Legal General Group Plc’s portfolio. Pensionfund Dsm Netherlands sold out all of its stake in CAH during the most recent quarter. The investment firm sold 48,000 shares of CAH which is valued $3,615,360.First United Bank Trust reduced its stake in CAH by selling 400 shares or 4.1% in the most recent quarter. The Hedge Fund company now holds 9,345 shares of CAH which is valued at $714,612. Cardinal Health Inc makes up approx 0.59% of First United Bank Trust’s portfolio.West Oak Capital boosted its stake in CAH in the latest quarter, The investment management firm added 75 additional shares and now holds a total of 210 shares of Cardinal Health Inc which is valued at $15,935. Cardinal Health Inc makes up approx 0.01% of West Oak Capital’s portfolio.

Cardinal Health Inc closed down -0.07 points or -0.09% at $75.27 with 14,69,061 shares getting traded on Friday. Post opening the session at $75.66, the shares hit an intraday low of $75.07 and an intraday high of $75.85 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Downgraded by Goldman to ” Neutral” on Sep 16, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.